Geneva (PRWEB UK) 13 February 2014
Tech Tour and the International Venture Club announced today that the 2014 Healthtech Summit will be held in Lausanne on June 23-24, 2014.
“The global healthcare environment is transforming rapidly. Value-based health, the maximization of health outcomes over cost is becoming the new normal. In this evolving framework, innovation in the medical space requires a renovated business ecosystem, where entrepreneurs, investors and corporations work constructively on combining breakthrough technologies with disruptive business models.
At this year’s Summit, we look forward to engaging the CEOs of the most creative, passionate and promising 20 healthtech emerging and growth companies to debate how to anticipate the challenges and deliver successful medical solutions to the marketplace!” said Angelo de Rosa, President HTS2014.
Since its inception in 2008, the Healthtech Summit has featured some of the most innovative medical technology companies with potential to make global impact in healthcare. Many of these emerging companies have successfully revolutionized the practice of medicine with improved medical outcomes for patients that benefit from their solutions.
“At this upcoming Summit we look forward to celebrating excellence in this sector by recognizing one of the biggest success stories of the past year with the 2014 Salus Partners Excellence in Healthtech Award", mentioned Brian Hashemi, Salus Partners
Company Registration – why should you register?
- No charge to apply
- No charge for selected companies to attend the event and present – selection is merit only based
- Companies are selected by an expert selection committee, according to their potential market impact
- Selected companies will present to a group of 100+ global investment professionals, advisors and corporates.
Applicants can register for the Summit at http://www.e-unlimited.com/events/view.aspx?events_pages_id=2034
As part of the process applicants must submit a corporate presentation together with the registration form.
The deadline for applications is March 13.
Applicants will be assessed on the uniqueness of their technology, the strength of their business model, vision, and capability to execute on the business plan and the quality and track record of their management. Submissions will be reviewed by the selection committee, which is comprised of senior business leaders from various backgrounds including venture capital, technology, research and economic promotion.
Rewards for Finalists
The selected 20 finalists will each have an opportunity to present their business plans to senior partners, vice presidents and CEOs from the global venture capital and technology industry, as well as service providers and academics. In addition, they will benefit from networking opportunities, local and international media exposure and potential opportunities to secure funding.
Previous Summit attendees included senior representatives of most major investment firms and corporates:
Addex, ARES Life Science, Auriga Partners, Baxter International, Bay City Capital, BioBay, Biosensors, Boston Scientific, CDC Innovation, Creathor Venture, Credit Agricole Private Equity, Credit Suisse, Cukierman & Co. Life Sciences, Decheng Capital, Delta Partners, DFJ Esprit, Earlybird Venture Capital, Edwards Life Science, EIF, Endeavour Vision, Eurofin Ventures, Entrepreneurs Fund Management, EPFL, EuroUS Ventures, Fountain, Healthcare Partners, Gilde Healthcare Partners, GIMV, Go4Ventures, Index Ventures, Inventure Capital, Johnson & Johnson, Kreos Capital, Linde Healthcare, Medtronic, MVM Life Science Partners, NASA, NeoMed, Novartis Ventures, Polytech Ventures, Rothschild Group, Scottish Equity Partners, Siemens, Sofimac Partners Investment Capital, Sofinnova, Sony, Stryker, Trigon Medical, Valtronic Technologies, Wellington Partners.
Companies that have presented in previous Summits have either been acquired or raised more than $1 Billion in funding. Some notable examples include:
BioControl Medical (2008) raised more than €70m in funding
Corevalve (2008) acquired by Medtronic for $700m
EOS Imaging fka Biospace Med (2008) €40m IPO in 2012
CeQur (2008 & 2010) $40m funding in 2010
Endosense (2008) raised more than $80m in funding
Novashunt (2008) raised more than $25m
Precimed (2007) acquired by Greatbach $125m
Optinose (2008) raised more than $48.5m
Symetis (2008) raised more than $25m in funding
Gynesonics (2010) $21m in funding
Miracor Medical Systems (2010) raised more than €13.5m
Sapiens (2010) raised more than €32m in funding
BMEYE (2010)acquired by Edwards Lifesciences $42m in 2012
Join our LinkedIn group: Tech Tour
Follow us on Twitter: #Tech_Tour #NordicTT14
Check out our videos on YouTube channel: http://youtube.com/EuropeanTechTour
About the Tech Tour
The Tech Tour was founded in Geneva in 1998 in response to the growing interest in emerging technology companies in various European regions. The Tech Tour is an independent, not-for-profit organization composed of key contributors to the high technology industry. The organization recognizes that continued prosperity in Europe lies in its ability to transform today's innovative projects into tomorrow's global technology leaders.
About the International Venture Club
The International Venture Club was founded in 2011 as the collaborative platform of leading venture investors promoting successful international investments. Its objectives are to 1) share better practices, 2) build co-investor trust and relations, 3) foster new funding and investment opportunities through joint actions and PR, 4) grow promising companies with corporate partners and co-investors and 5) keep a smart window and support to emerging innovative companies.
International Venture Club
+32 (0) 2 643 36 94
+41 22 544 60 63
+44 20 7409 5240